Abstract
No public abstract is available from the verified source records.
Xiaonan Lin, Yaling Zheng, Yongzhong Su, FeiHeng Chen, Shaoze Lin, Zhenqian Huang, Yaya Wang, Jihao Zhou, Lina Hu, Yuexiong Liang, Shuyi Mo, Jinxiong Huang, 古学奎, Zenghui Liu, Xiaoli Xu, Sanfang Tu, Chunyan Yue, Shaojie Wu, Chaoyang Song, Yuhua Li
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Acute myeloid leukaemia
10.1016/s0140-6736(23)00108-3 · 2023
Mortality and premature life lost from leukemia in China, 2005-2020: A study based on the National Mortality Surveillance System
10.1097/cm9.0000000000003946 · 2026
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML
10.1182/blood.2024027217 · 2025
Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML
10.1182/blood.2023020102 · 2023
Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: A retrospective propensity score matching study
10.1038/s41408-023-00948-x · 2023
No additional external references are available.
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%